GGrantIndex
Sort

48,018 grants matching immunotherapy

(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade

$599,504
Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2019 · CA

Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas

$599,474
Luis Solorio · Purdue University · R01 · FY2024 · CA

Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies

$599,469
Richard J Simpson · University Of Arizona · R01 · FY2024 · CA

Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study

$599,442
Rebecca Ashare · State University Of New York At Buffalo · U01 · FY2024 · CA

(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis

$599,301
Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2023 · CA

Tailoring CAR T cell therapy for Hodgkin Lymphoma

$599,281
Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity

$599,268
Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2020 · CA

Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity

$599,268
Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2021 · CA

Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC

$599,214
Phuoc T. Tran · University Of Maryland Baltimore · R01 · FY2025 · CA

Two-way Magnetic Resonance Tuning Nanoprobe Enhanced Subtraction Imaging for Precision Diagnosis of Brain Metastasis

$599,174
Yuanpei Li · University Of California At Davis · R01 · FY2025 · EB

Small Animal Irradiator with Cone Beam CT

$599,155
Ross B Mikkelsen · Virginia Commonwealth University · S10 · FY2011 · RR

Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer

$599,135
Andrew T Chan · Massachusetts General Hospital · R01 · FY2023 · CA

Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model

$598,999
Ryan C Fields · Washington University · R01 · FY2021 · CA

Regulators of Cancer Immunotherapy Response

$598,991
Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2022 · CA

AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS

$598,885
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Characterization of multilineage definitive hematopoietic progenitors from human pluripotent stem cells

$598,877
Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HL

Characterization of multilineage definitive hematopoietic progenitors from human pluripotent stem cells

$598,877
Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria

$598,787
Molly A Hughes · University Of Virginia · R01 · FY2020 · AI

Ovarian Cancer Epigenetics, Immunity and Therapy

$598,764
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

NCI X-ray free electron laser (XFEL) initiative

$598,705
Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Mast cell regulation of Th2 induction and tolerance breakdown in food allergy

$598,688
Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2022 · AI

Mast cell regulation of Th2 induction and tolerance breakdown in food allergy

$598,688
Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2024 · AI

Mast cell regulation of Th2 induction and tolerance breakdown in food allergy

$598,688
Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2023 · AI

Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling

$598,647
Casey S Greene · University Of Colorado Denver · R01 · FY2021 · CA

Immune Enhancement and Therapy of Cancer

$598,634
Douglas Hanahan · University Of California, San Francisco · U01 · FY2007 · CA